ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

48,055Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 1469

$4.97M Total Retail Price of All Prescriptions

Rank: 1 out of 1469

1,252 Patients Receiving at Least One Drug in Part D
98% Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 1,252 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Brand Name Drugs

59% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%. This is far more than peers.

Prescription Price

$104 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
BYSTOLIC 3,293 3,220 354 10 1 29
CRESTOR 2,162 2,126 268 10 2 15
DIOVAN 1,709 1,698 189 10 3 14
XARELTO 1,530 1,530 159 10 4 24
ATORVASTATIN CALCIUM 1,352 1,323 164 5 1
AMIODARONE HCL 1,318 1,318 159 10 6 20
LOVAZA 1,254 1,228 131 7 42
NEXIUM 1,148 1,143* 128 8 47
VALSARTAN-HYDROCHLOROTHIAZIDE 1,141 1,136* 147 10 9 37
DEXILANT 994 981 121 10 10 84
LEVOTHYROXINE SODIUM 934 929* 99 11 21
CAPTOPRIL 862 857* 122 10 12 120
CARVEDILOL 818 802 86 13 2
FUROSEMIDE 809 804* 107 14 8
CLOPIDOGREL 801 783 90 15 5
ATENOLOL 778 778 91 16 12
ALLOPURINOL 776 764 80 17 45
METOPROLOL SUCCINATE 736 717 84 18 4
RANEXA 685 680* 74 10 19 33
CLONAZEPAM 679 674* 89 B 20 114
ZETIA 672 667* 69 21 27
BENICAR HCT 612 607* 70 10 22 85
SIMVASTATIN 585 580* 61 23 6
ESCITALOPRAM OXALATE 576 571* 87 24 86
LORAZEPAM 568 563* 93 B 25 60
SYNTHROID 557 557 60 26 87
METFORMIN HCL 492 475 72 27 25
BENICAR 468 454 53 28 49
DIOVAN HCT 467 462* 100 10 29 122
PRAVASTATIN SODIUM 466 466 50 30 19
LOSARTAN-HYDROCHLOROTHIAZIDE 466 454 48 30 32
AMLODIPINE BESYLATE 445 440* 65 32 3
ISOSORBIDE MONONITRATE ER 430 425* 43 33 13
METOPROLOL TARTRATE 428 423* 57 34 10
EXFORGE 420 420 55 35 89
JANUMET 412 407* 42 36 127
ZOLPIDEM TARTRATE 349 344* 55 37 34
PROPRANOLOL HCL 349 349 41 37 97
IBANDRONATE SODIUM 341 341 43 39 132
MECLIZINE HCL 332 332 43 40 104
SPIRONOLACTONE 329 329 53 41 22
POTASSIUM CHLORIDE 329 329 53 41 18
KLOR-CON 8 321 321 41 43 73
CYMBALTA 318 318 38 44 117
OMEPRAZOLE 316 316 33 45 23
TRAMADOL HCL 310 310 53 46 55
LIDODERM 299 299 39 47 83
MICARDIS HCT 298 298 33 10 48 207
ADVAIR DISKUS 297 297 36 49 77
JANUMET XR 285 280* 30 10 50 231
TRILIPIX 264 252 33 51 123
LOSARTAN POTASSIUM 258 258 37 52 11
ACTONEL 232 232 29 53 156
WARFARIN SODIUM 218 218 25 54 9
MICARDIS 215 215 26 10 55 144
DONEPEZIL HCL 213 213 22 56 66
CLONIDINE HCL 212 188 40 57 43
COREG CR 209 209 24 10 58 125
TAMSULOSIN HCL 205 205 28 59 44
JANUVIA 194 189* 26 60 64
CREON 193 188* 28 61 157
EVISTA 190 190 18 62 149
PANTOPRAZOLE SODIUM 188 183* 25 63 41
RAMIPRIL 186 186 22 64 35
HYDRALAZINE HCL 177 172* 26 65 36
CELEBREX 163 158* 18 66 81
MONTELUKAST SODIUM 160 160 19 67 70
FENOFIBRATE* 158 158 17 68 54
LIPITOR 154 149* 22 10 69 236
NITROSTAT 151 146* 30 70 30
ULORIC 146 146 20 71 134
NITROLINGUAL 146 146 34 10 71 206
SPIRIVA 146 146 18 71 101
DOXAZOSIN MESYLATE 139 128 16 74 58
TEMAZEPAM 137 137 25 B 75 110
MULTAQ 136 136 14 76 57
AVODART 133 133 14 77 112
AZOR 133 133 18 77 119
RAPAFLO 131 131 18 79 224
LUNESTA 125 120* 21 80 229
NATEGLINIDE 123 111 12 81 164
LINZESS 123 118* 33 81 222
DALIRESP 120 120 13 83 263
GLIMEPIRIDE 120 120 18 83 63
VASCEPA 118 113* 40 85 126
VYTORIN 113 113 16 86 94
RANITIDINE HCL 110 110 13 87 108
PLAVIX 107 102* 22 88 210
EDARBYCLOR 102 87 21 89 193
AMLODIPINE BESYLATE-BENAZEPRIL 99 94* 13 90 74
VESICARE 97 97 11 91 184
PRADAXA 97 97 12 91 28
TEKTURNA 96 96 25 93 189
AGGRENOX 95 95 11 94 257
VOLTAREN 92 92 19 95 80
VERAPAMIL ER 82 <11 <11 96 102
PROAIR HFA 80 <11 <11 97 82
CILOSTAZOL 79 79 11 98 93
AMITIZA 78 78 11 99 182
EXFORGE HCT 76 <11 <11 100 183
ALENDRONATE SODIUM 75 <11 <11 101 50
EDARBI 75 70* 14 101 225
FENOFIBRIC ACID 75 75 17 101 227
GABAPENTIN 75 <11 <11 101 48
PRIMIDONE 74 <11 <11 105 306
TUDORZA PRESSAIR 72 72 17 106 270
SERTRALINE HCL 71 <11 <11 107 96
BENAZEPRIL HCL 71 <11 <11 107 26
LEVOFLOXACIN 68 68 55 109 128
EFFIENT 67 <11 <11 110 68
COUMADIN 66 <11 <11 111 116
ENALAPRIL MALEATE 64 <11 <11 112 52
TRADJENTA 62 62 14 113 171
HYDROCODONE-ACETAMINOPHEN 61 50 14 S3 114 31
NASONEX 59 <11 <11 115 150
CALCITRIOL 59 <11 <11 115 226
LYRICA 59 <11 <11 115 147
WELCHOL 55 <11 <11 118 106
NIFEDIPINE ER 54 <11 <11 119 59
COLCRYS 52 47* 18 120 188
LANSOPRAZOLE 52 <11 <11 120 198
TRIBENZOR 51 <11 <11 122 146
PAROXETINE HCL 51 <11 <11 122 129
BISOPROLOL FUMARATE 50 <11 <11 124 71
NAMENDA 50 <11 <11 124 78
AZITHROMYCIN 50 45* 43 124 79
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.